Coumadin
Bibliografia - Quali fonti bibliografiche per Warfarin?
- Abu Sham’a R.A. et al., Int. J. Lab. Hematol., 2008, 30(4), 339.
- ACTIVE Writing Group of the ACTIVE Investigators et al., Lancet, 2006, 367, 1903.
- American Psychiatric Association, Annual Meeting, 2014, 4 maggio, Abstract NR3-14.
- Anderson D.R. et al., Haemostasis., 1992, 22(3), 124.
- Banfield C. et al., Br. J. Clin. Pharmacol., 1983, 16, 669.
- Brookenthal K.R. et al., J. Arthroplasty, 2001, 16, 293.
- Chonlahan J. et al., Pharmacotherapy., 2006, 26(6), 868.
- Choonara I.A. et al., Br. J. Pharmacol., 1986, 21, 271.
- Clark S.L. et al., Obstet. Gynecol., 2000, 95 (6 Pt 1), 938.
- Dager W.E. et al., Pharmacotherapy., 2007, 27(4), 564.
- Downie A.C. et al., Clin. Experiment. Ophthalmol., 2009, 37(6), 624.
- Drugs and therapeutics bulletin, 2000, 9 ,12.
- Flockhart D.A. et al., Genet. Med., 2008, 10, 139.
- Fountain R.B. et al., Am. Heart J., 2006, 151(5), 956.
- Geerts W.H. et al., Chest, 2008, 133, 381s.
- Go A.S., NEJM, 2009, 360, 2127.
- Hazlewood K.A. et al., Ann. Pharmacother., 2006, 40(12), 2101.
- Heart Rhythm Society, session: “Atrial Fibrillation patients treated with long-term warfarin anticoagulation have higher rates of all dementia types compared to patients receiving warfarin long-term for other indications”, 2016. Disponibile on-line: http://www.hrsonline.org/News/Press-Releases/2016/05/New-Study-Shows-Atrial-Fibrillation-Patients-Treated-with-Warfarin-Long-Term-are-at-Increased-Risk-for-Dementia
- Heimark L.D. et al., Clin. Pharmacol. Ther., 1987, 42, 388.
- Holmes L.B., Am. J. Med. Genet., 2002, 112(3), 297.
- Holmes D.R. et al., Lancet, 2009, 374 (9689), 534.
- Hou J.W., Chang. Gung. Med. J., 2004, 27(9), 691.
- Jacobs V. et al., J. Cardiovasc. Electrophysiol., 2015, doi: 10.1111/ jce.12776.
- Jagasia D.H. et al., Curr. Opin. Cardiol., 2000, 15(1), 58.
- Joss J.D., LeBlond R.F., Ann. Pharmacother., 2000, 34(6), 729.
- Kahn A.O., Ophthalmic. Genet., 2007, 28(3), 183.
- Kaplan L.C., Teratology., 1985, 32(3), 333-7.
- Kates R.E. et al., Clin. Pharmacol. Ther., 1987, 42, 305.
- Laizure S.C. et al., Ther. Drug Monit., 1997, 19(3), 361.
- Lenzini P.A. et al., Ann. Pharmacother., 2007, 41, 1798.
- Mac Walter R.S. et al., Ann. Pharmacother., 2003, 37(4), 510.
- Madabushi R. et al., Eur. J. Clin. Pharmacol., 2006, 62 (3), 225.
- Martinowitz U. et al., NEJM, 1981, 304, 671.
- Masamoto H. et al., Am. J. Perinatol., 2009, 26(8), 597.
- Mehndiratta S. et al., Arch. Gynecol. Obstet., 2010, 282 (3), 335.
- Menon R.K. et al., Clin. Chem., 1986, 32 (8), 1557.
- Millican E. et al., Blood, 2007, 110, 1511.
- O’Reilly R.A. et al., NEJM, 1976, 295, 354. 10.1007/s11239-015-1226-2
- Ogunsua A.A. et al., J. Thromb. Thrombolysis, 2015, doi: 10.1007/ s11239-015-1226-2.
- Oswal K., Agarwal A., J. Clin. Ultrasound., 2008, 36(7), 451.
- Pati S., Helmbrecht G.D., Reprod. Toxicol., 1994, 8(2), 115.
- Raivio K.O. et al., Acta Paediatr. Scand., 1977, 66(6), 735.
- Rieder M.J. et al., NEJM, 2005, 352, 2285.
- Rindone J.P. et al., Am. J. Ther., 2010, 9.
- Sathienkijkanchai A, Wasant P., J. Med. Assoc. Thai., 2005, 88 (Suppl 8), S246.
- Schaefer C. et al., Thromb. Haemost., 2006, 95 (6), 949.
- Simonazzi G. et al., Prenat. Diagn., 2008, 28(2), 157.
- Small N.L., Giamonna K.A., Ann. Pharmacother., 2000, 34(6), 734.
- Snyder D.S., Ann. Intern. Med. 1988, 53, 291.
- Takahashi H. et al., Clin. Pharmacol. Ther., 1999, 66(6), 569.
- Teefy A.M. et al., Ann. Pharmacother., 2000, 34(11), 1265.
- Thijssen H.H. et al., Thromb. Haemost., 2004, 92, 797.
- Thoongsuwan N., Stern E.J., J. Thorac. Imaging., 2003, 18(2), 110.
- Toon S. et al., Clin. Pharmacol. Ther., 1986, 39, 15.
- Ville Y. et al., Lancet, 1993, 341, 1211.
- Vitale N. et al., J. Am. Coll. Cardiol., 1999, 33(6), 1637.
- von Rosenstiel N., Adam D., Drugs, 1994, 47 (6), 872.
- Voora D. et al., Thromb. Haemost., 2005, 93, 700.
- Warkentin T.E. et al., Ann. Intern. Med., 1997, 127(9), 804.